Literature DB >> 6429469

Fatty acid metabolism and cell proliferation. V. Evaluation of pathways for the generation of lipid peroxides.

N Morisaki, J A Lindsey, J M Stitts, H Zhang, D G Cornwell.   

Abstract

Primary cultures of smooth muscle cells were established from the medial layer of guinea pig aorta. Confluent cells at passage level 4-6 were challenged with arachidonic acid and treated with a number of antioxidants and inhibitors of specific lipid peroxidation pathways. Lipid peroxidation was measured by the thiobarbituric acid test for malondialdehyde (MDA) and the isolation of hydroperoxy fatty acids (HPETE) by high performance liquid chromatography (HPLC). Prostanoids were measured by radioimmunoassay and the separation of labeled compounds by HPLC. MDA, 6-keto-PGF1 alpha, and PGE2 were formed when cells were challenged with arachidonic acid and these cells synthesized small amounts of one HPETE isomer, 15-HPETE. The HPETE isomers characteristic of the lipoxygenase pathway, 12-HPETE and 5-HPETE, were not detected. Furthermore, the lipoxygenase inhibitors, eicosatetraynoic acid (ETYA) and 6,7-dihydroxycoumarin (Esculetin), did not block MDA formation. These data show that MDA is not generated in the cells by a lipoxygenase pathway. The cyclooxygenase inhibitors, indomethacin and ETYA, did not block MDA formation but these agents blocked the formation of 15-HPETE. These data show both that 15-HPETE is generated by a cooxidation pathway and that 15-HPETE and cooxidation are not involved in MDA formation. Three inhibitors of cytochrome P450 linked lipid peroxidation, 2-amino-3-ethoxycarbonyl-6-benzyl-4, 5,6,7-tetrahydrothieno-[2,3-C]-pyridine (Tinoridine), 3-methyl-1,2-di-3-pyridyl-1-propanone (Metyrapone) and phenobarbital, did not block MDA formation. These data support earlier studies that indicated that MDA is not generated by a P450 pathway. Cells contained a bound precursor that decomposed to MDA when cells were treated with Fe3+. The cells exhibited autofluorescence and concentric lamellae in lipid droplets that are characteristic of ceroid-lipofuscin. These observations are consistent with lipid peroxidation through increased peroxisomal activity leading to the generation of MDA and the accumulation of ceroid-lipofuscin. The natural antioxidants, vitamin E and vitamin E quinone (EQ), and the synthetic antioxidants, butylated hydroxytoluene and nordihydroguaiaretic acid (NDGA), alpha-naphthol (alpha-N) and propyl gallate (PrGa), all blocked MDA formation in confluent smooth muscle cells, showing that these antioxidants did not function solely as specific inhibitors of lipoxygenase, cooxidation or P450 pathways. Cell proliferation was measured in cells challenged with arachidonic acid and treated with antioxidants and other inhibitors. The least cytotoxic and most potent antioxidant, EQ, blocked MDA formation in confluent cells and promoted grow

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6429469     DOI: 10.1007/bf02537399

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  41 in total

1.  The production of the arachidonate metabolite HETE in vascular tissue.

Authors:  J E Greenwald; J R Bianchine; L K Wong
Journal:  Nature       Date:  1979-10-18       Impact factor: 49.962

2.  Effect of temperature and antioxidants upon the lipoxidase-catalyzed oxidation of sodium linoleate.

Authors:  A L TAPPEL; W O LUNDBERG; P D BOYER
Journal:  Arch Biochem Biophys       Date:  1953-02       Impact factor: 4.013

3.  High-pressure liquid chromatography of underivatized fatty acids, hydroxy acids, and prostanoids having different chain lengths and double-bond positions.

Authors:  M Van Rollins; M I Aveldańo; H W Sprecher; L A Horrocks
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

4.  Image analysis for the automated estimation of clonal growth and its application to the growth of smooth muscle cells.

Authors:  V C Gavino; G E Milo; D G Cornwell
Journal:  Cell Tissue Kinet       Date:  1982-03

5.  Preparation and purification of lipid hydroperoxides from arachidonic and gamma-linolenic acids.

Authors:  M O Funk; R Isacc; N A Porter
Journal:  Lipids       Date:  1976-02       Impact factor: 1.880

6.  Conversion of 8,11,14-eicosatrienoic acid to 11,12-epoxy-10-hydroxy-8-heptadecenoic acid by aorta.

Authors:  C D Funk; W S Powell
Journal:  Prostaglandins       Date:  1983-02

7.  Effect of polyunsaturated fatty acids and antioxidants on lipid peroxidation in tissue cultures.

Authors:  V C Gavino; J S Miller; S O Ikharebha; G E Milo; D G Cornwell
Journal:  J Lipid Res       Date:  1981-07       Impact factor: 5.922

8.  Polyunsaturated fatty acid accumulation in the lipids of cultured fibroblasts and smooth muscle cells.

Authors:  V C Gavino; J S Miller; J M Dillman; G E Milo; D G Cornwell
Journal:  J Lipid Res       Date:  1981-01       Impact factor: 5.922

9.  Formation of 6-oxoprostaglandin F1 alpha, 6,15-dioxoprostaglandin F1 alpha, and monohydroxyicosatetraenoic acids from arachidonic acid by fetal calf aorta and ductus arteriosus.

Authors:  W S Powell
Journal:  J Biol Chem       Date:  1982-08-25       Impact factor: 5.157

10.  Fatty acid specificity in the inhibition of cell proliferation and its relationship to lipid peroxidation and prostaglandin biosynthesis.

Authors:  N Morisaki; H Sprecher; G E Milo; D G Cornwell
Journal:  Lipids       Date:  1982-12       Impact factor: 1.880

View more
  11 in total

1.  Studies on lipid peroxidation in normal and tumour tissues. The Novikoff rat liver tumour.

Authors:  K H Cheeseman; M Collins; K Proudfoot; T F Slater; G W Burton; A C Webb; K U Ingold
Journal:  Biochem J       Date:  1986-04-15       Impact factor: 3.857

2.  Physiologic and molecular changes in the tracheal epithelium of rats following burn injury.

Authors:  Sam Jacob; Yong Zhu; Robert Kraft; Christopher Cotto; Joseph R Carmical; Thomas G Wood; Perenlei Enkhbaatar; David N Herndon; Hal K Hawkins; Robert A Cox
Journal:  Int J Burns Trauma       Date:  2015-03-20

3.  Deficiency of vitamin E in the alveolar fluid of cigarette smokers. Influence on alveolar macrophage cytotoxicity.

Authors:  E R Pacht; H Kaseki; J R Mohammed; D G Cornwell; W B Davis
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

4.  Role of CYP eicosanoids in the regulation of pharyngeal pumping and food uptake in Caenorhabditis elegans.

Authors:  Yiwen Zhou; John R Falck; Michael Rothe; Wolf-Hagen Schunck; Ralph Menzel
Journal:  J Lipid Res       Date:  2015-09-23       Impact factor: 5.922

5.  Role of prostanoids and lipid peroxides as mediators of the 12-O-tetradecanoylphorbol-13-acetate effect on cell growth.

Authors:  N Morisaki; L D Tomei; G E Milo; D G Cornwell
Journal:  Lipids       Date:  1985-09       Impact factor: 1.880

6.  Role of phospholipase A2 in expression of the scavenger pathway in cultured aortic smooth muscle cells stimulated with phorbol 12-myristate 13-acetate.

Authors:  N Morisaki; K Yokote; K Takahashi; M Otabe; Y Saito; S Yoshida; S Ueda
Journal:  Biochem J       Date:  1994-10-01       Impact factor: 3.857

7.  Fatty acid metabolism and cell proliferation. VII. Antioxidant effects of tocopherols and their quinones.

Authors:  J A Lindsey; H F Zhang; H Kaseki; N Morisaki; T Sato; D G Cornwell
Journal:  Lipids       Date:  1985-03       Impact factor: 1.880

8.  Action of bradykinin at the cyclooxygenase step in prostanoid synthesis through the arachidonic acid cascade.

Authors:  H Zhang; T S Gaginella; X Chen; D G Cornwell
Journal:  Agents Actions       Date:  1991-11

9.  Studies on lipid peroxidation in normal and tumour tissues. The Yoshida rat liver tumour.

Authors:  K H Cheeseman; S Emery; S P Maddix; T F Slater; G W Burton; K U Ingold
Journal:  Biochem J       Date:  1988-02-15       Impact factor: 3.857

10.  d-alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties.

Authors:  A Tasinato; D Boscoboinik; G M Bartoli; P Maroni; A Azzi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.